Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. A. F. Simoes, X. Carbonell-Estrany, J. L. L. Kimpen, C. H. L. Rieger, I. Mitchell, L. M. Fredrick, A. Campbell, J. R. Groothuis (Denver CO, Abbott Park, Gaithersburg, United States Of America; Barcelona, Spain; Utrecht, Netherlands; Bochum, Germany; Ca. Palivizumab prophylaxis, subsequent recurrent wheezing and atopy. Eur Respir J 2008; 32: Suppl. 52, 1444

Member's Comments

No comment yet.

Related content which might interest you: The effect of palivizumab prophylaxis on serious early childhood wheezing Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009 Febrile respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze Source: Eur Respir J 2012; 39: 876-882 Year: 2012 RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life Source: Eur Respir J 2002; 20: 1277-1283 Year: 2002 Hospitalisation for RSV bronchiolitis and the risk of wheezing disorders and atopy Source: ISSN=ISSN 1810-6838, ISBN=, page=171 Year: 2005 The effects of respiratory infections, atopy, and breastfeeding on childhood asthma Source: Eur Respir J 2002; 19: 899-905 Year: 2002 Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach Source: Eur Respir J 2008; 32: 1096-1110 Year: 2008 Fever episodes in early life and the development of atopy in children with asthma Source: Eur Respir J 2002; 20: 391-396 Year: 2002 Is fungal sensitisation associated with exacerbation-prone or severe preschool wheezing? Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Inhaled corticotherapy in atopic toddlers with recurrent wheezing Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003 Palivizumab prophylaxis, respiratory syncytial virus and subsequent recurrent wheezing: a 2-year follow-up study Source: Eur Respir J 2006; 28: Suppl. 50, 758s Year: 2006 Does paracetamol use increase the risk of recurrent wheeze or atopy in young children? Source: Eur Respir J 2001; 18: Suppl. 33, 523s Year: 2001 Risk factors for recurrent wheezing after viral bronchiolitis - is there a relationship with subsequent asthma? Source: Eur Respir J 2003; 22: Suppl. 45, 138s Year: 2003 The significance of early recurrent wheeze for asthma outcomes in late childhood Source: Eur Respir J 2013; 41: 838-845 Year: 2013 Impact of COVID-19 side-effects on pediatric and adult patients with recurrent wheeze and asthma Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up Source: Eur Respir J 2012; 39: 396-402 Year: 2012 Day care attendance, recurrent infections, wheezing and eczema Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy Year: 2012 Epidemiology of respiratory infection in children Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children Year: 2005 Palavizumab use decreases risk of recurrent wheezing in preterm children Source: Eur Respir J 2004; 24: Suppl. 48, 212s Year: 2004 Risk factors for wheezing and allergy in preschool children (PSC) after admission for acute bronchiolitis Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011